Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Pharmacokinetics|August 28, 2016
Appropriate risk criteria for OATP inhibition at the drug discovery stage based on the clinical relevancy between OATP inhibitors and drug-induced adverse effectMasanori Nakakariya, Akihiko Goto, Nobuyuki Amano
Biopharmaceutics & Drug Disposition|November 7, 2022
Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectivesAkihiko Goto, Syunsuke Yamamoto, Shinji Iwasaki
Respiratory Investigation|November 6, 2024
A systematic review of factors associated with poor prognosis despite appropriate antibiotics usage for pneumoniaAkihiko Goto, Kentaro Ishikawa, Kosaku Komiya
Proceedings. Biological Sciences|January 29, 2025
Latitudinal cline of ocean dependence in a diadromous fishAkihiko Goto, Mari Kuroki, Kentaro Morita
Cureus|December 26, 2025
Systematic Review of Clinical and Imaging Features for Differentiating Pulmonary Tuberculosis and Nontuberculous Mycobacterial Pulmonary DiseasesAkihiko Goto, Ishikawa Kentaro, Taisei Hirakawa, et al.
Cureus|December 9, 2024
Difference of Clinical Manifestation Between Infection and Colonization of Pseudomonas aeruginosa Among Patients With Community-Acquired PneumoniaShoma Hirota, Akihiko Goto, Hisayuki Shuto, et al.
Molecular Pharmaceutics|July 10, 2007
Transport of organic cations across the blood-testis barrierTomoji Maeda, Akihiko Goto, Daisuke Kobayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 22, 2004
[Successful treatment of acute myelomonocytic leukemia developed from essential thrombocythemia with cytarabine plus etoposide]Yuko Ishii, Akihiko Goto, Tomoko Katagiri, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 28, 2005
[A case report of cholesteatoma of the ureter difficult to distinguish from malignant ureter tumor]Yoichi Tamura, Yasushi Yumura, Yutaka Senga, et al.
Drug Metabolism and Pharmacokinetics|June 6, 2024
DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challengesAkihiko Goto, Yuu Moriya, Miyu Nakayama, et al.
Pageof 5